Warning

Read page 6

This authorization also covers the use of the licensed COMIRNATY (COVID-19 Vaccine, mRNA) product when used to provide a two-dose regimen for individuals aged12 through 15 years,or to provide a third dose to individuals 12 years of age or older who haveundergone solid organ transplantationor who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.